In another study, combination therapy involving ATR inhibitor (ATRi) BAY1895344 and anti-PD-L1 demonstrated greater inhibition and survival of tumor bearing mice compared to using either of the individual agents alone in RM-1-BM mouse PCa model 198. Here, CD274 is linked to neoplasm.